コーパス検索結果 (1語後でソート)
通し番号をクリックするとPubMedの該当ページを表示します
3 e study of the characteristics of women with somatoform and factitious disorders who involve their ch
5 ts assigned ozanimod 0.5 mg: optic neuritis, somatoform autonomic dysfunction, and cervical squamous
6 ith less dramatic features, fewer additional somatoform complaints, and lower dissociation scores.
7 d disorder (6.5%; 95% CI, 5.5% to 7.5%), any somatoform/conversion disorder (5.3%; 95% CI, 4.3% to 6.
9 line personality disorder (factors 3 and 4), somatoform disorder (factors 1 and 2), paranoid and depe
10 he basis of DSM-IV criteria and absence of a somatoform disorder and a plausible medical explanation.
12 patients, however, no conclusive features of somatoform disorder or psychogenic disorder can be found
13 iodemographic characteristics, patients with somatoform disorder still had more primary care visits (
17 ommon current psychiatric diagnoses included somatoform disorders (89%), dissociative disorders (91%)
18 stent with advancing research on anxiety and somatoform disorders and offers greater insights into th
23 osis, mania, and cluster A PDs), somatoform (somatoform disorders), and antagonism (cluster B and par
25 mood disorders, neurotic stress-related and somatoform disorders, and a range of developmental and c
26 t nonepileptic seizures are in a spectrum of somatoform disorders, diagnostic literature is reviewed
27 ology and maintenance of somatic disease and somatoform disorders, is an important factor in the beha
28 the diagnoses subsumed under the category of somatoform disorders, various nosological questions are
32 ood disorders; neurotic, stress-related, and somatoform disorders; eating disorders; specific persona
33 her anxiety disorders, eating disorders, and somatoform disorders; higher scores on most subscales of
34 psychotic, posttraumatic stress or anxiety, somatoform, neurocognitive, and eating disorders, as wel
35 order (psychosis, mania, and cluster A PDs), somatoform (somatoform disorders), and antagonism (clust
37 umber of physical symptoms and the number of somatoform symptoms correlated with difficulty (r = 0.39
38 s and physician-assessed psychopathology and somatoform symptoms were evaluated by using the PRIME-MD
39 ve Experiences Scale, and Screening Test for Somatoform Symptoms) a mean of 11.9 years after manifest
WebLSDに未収録の専門用語(用法)は "新規対訳" から投稿できます。